Oral Genome
PrivateLast Round
SAFE
Jun 26, 2026
Est. Valuation
$375,000
Total Funding Raised
$110,000
Company Overview
Oral Genome is a biotechnology company that provides point-of-care salivary testing kits to analyze biomarkers for oral and systemic diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Medical AI, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oral Genome Comparables
Compare Oral Genome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Drūl | 84% | |
| Spectrum Solutions | 79% | |
| SuperTruth | 77% |
Oral Genome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Jun 26, 2026 | ||||
| Strategic | Mar 5, 2024 | ||||
| Seed | Dec 1, 2022 | ||||
| Accelerator | Sep 10, 2021 |
Key People
Founding team and executive leadership
Oral Genome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| American Dental Association | Strategic |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 17, 2025
Received the 2025 Cellerant Best of Class Hygiene Award for oral care innovation.
- Nov 7, 2025
Michael Shuman appointed as the new Chief Revenue Officer.
Recent news
Latest coverage and updates
- receives_financingJun 26, 2026
Oral Genome LLC received financing of $50K in investment on Jun 26th '26.
Oral Genome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Oral Genome's valuation, stock price, and market status.
Is Oral Genome a public or private company?
Oral Genome is a private company.
What is the current stock price of Oral Genome?
Oral Genome is a private company with no public stock price. No recent secondary market data is available.
How much is Oral Genome worth (valuation)?
Valuation information for Oral Genome is not publicly available.
Can I buy Oral Genome stock?
Oral Genome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Oral Genome's last funding round?
Oral Genome's most recent funding round was Strategic on March 5, 2024.
Who are the main investors in Oral Genome?
Key investors in Oral Genome include American Dental Association.
Will Oral Genome IPO soon?
No public IPO plans have been announced for Oral Genome.
How can I track Oral Genome secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Oral Genome's secondary market activity and sign up for updates.